99 related articles for article (PubMed ID: 12771185)
1. BTG2 antiproliferative protein interacts with the human CCR4 complex existing in vivo in three cell-cycle-regulated forms.
Morel AP; Sentis S; Bianchin C; Le Romancer M; Jonard L; Rostan MC; Rimokh R; Corbo L
J Cell Sci; 2003 Jul; 116(Pt 14):2929-36. PubMed ID: 12771185
[TBL] [Abstract][Full Text] [Related]
2. Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1, the human homolog of a component of the yeast CCR4 transcriptional complex: involvement in estrogen receptor alpha signaling pathway.
Prévôt D; Morel AP; Voeltzel T; Rostan MC; Rimokh R; Magaud JP; Corbo L
J Biol Chem; 2001 Mar; 276(13):9640-8. PubMed ID: 11136725
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of the 1.0 MDa CCR4-NOT complex identifies two novel components of the complex.
Chen J; Rappsilber J; Chiang YC; Russell P; Mann M; Denis CL
J Mol Biol; 2001 Dec; 314(4):683-94. PubMed ID: 11733989
[TBL] [Abstract][Full Text] [Related]
4. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
Tirone F
J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
[TBL] [Abstract][Full Text] [Related]
5. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
6. HTRP--an immediate-early gene product induced by HSV1 infection in human embryo fibroblasts, is involved in cellular co-repressors.
Li JF; Liu LD; Ma SH; Che YC; Wang LC; Dong CH; Zhao HL; Liao Y; Li QH
J Biochem; 2004 Aug; 136(2):169-76. PubMed ID: 15496587
[TBL] [Abstract][Full Text] [Related]
7. BTG2, its family and its tutor.
Duriez C; Moyret-Lalle C; Falette N; El-Ghissassi F; Puisieux A
Bull Cancer; 2004; 91(7-8):E242-53. PubMed ID: 15381462
[TBL] [Abstract][Full Text] [Related]
8. Human Ccr4-Not complexes contain variable deadenylase subunits.
Lau NC; Kolkman A; van Schaik FM; Mulder KW; Pijnappel WW; Heck AJ; Timmers HT
Biochem J; 2009 Aug; 422(3):443-53. PubMed ID: 19558367
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
Puisieux A; Magaud JP
Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
Donato LJ; Suh JH; Noy N
Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
[TBL] [Abstract][Full Text] [Related]
11. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
[TBL] [Abstract][Full Text] [Related]
12. The Ccr4-Not complex independently controls both Msn2-dependent transcriptional activation--via a newly identified Glc7/Bud14 type I protein phosphatase module--and TFIID promoter distribution.
Lenssen E; James N; Pedruzzi I; Dubouloz F; Cameroni E; Bisig R; Maillet L; Werner M; Roosen J; Petrovic K; Winderickx J; Collart MA; De Virgilio C
Mol Cell Biol; 2005 Jan; 25(1):488-98. PubMed ID: 15601868
[TBL] [Abstract][Full Text] [Related]
13. Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the murine homolog of a component of the yeast CCR4 transcriptional regulatory complex.
Rouault JP; Prévôt D; Berthet C; Birot AM; Billaud M; Magaud JP; Corbo L
J Biol Chem; 1998 Aug; 273(35):22563-9. PubMed ID: 9712883
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
15. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death.
Hong JW; Ryu MS; Lim IK
J Biol Chem; 2005 Jun; 280(22):21256-63. PubMed ID: 15788397
[TBL] [Abstract][Full Text] [Related]
17. B-cell translocation gene 2 (Btg2) regulates vertebral patterning by modulating bone morphogenetic protein/smad signaling.
Park S; Lee YJ; Lee HJ; Seki T; Hong KH; Park J; Beppu H; Lim IK; Yoon JW; Li E; Kim SJ; Oh SP
Mol Cell Biol; 2004 Dec; 24(23):10256-62. PubMed ID: 15542835
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
20. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
